Flow Cytometry Research Facility (FCRF) In 2014 the Flow Cytometry Research Facility (FCRF), formerly the Cell Analysis Facility, was re-branded to more accurately reflect the services offered. The FCRF is located in the Durham Research Center at the University of Nebraska Medical Center (UNMC) campus. The goal of the FCRF is to provide access to the latest instrumentation, leading scientific and technical expertise, with comprehensive flow cytometry support to all investigators at the University of Nebraska and the surrounding area. The facility houses two multicolor cell sorters with 14 simultaneous fluorescent parameter capabilities, one of which is contained within a class 2A biological safety cabinet. There are three analog analysis instruments with exceptional low-end resolution, ideal for DNA synthesis measurements. There are two high-end, multi-laser and multi-parameter flow cytometers with 14 and 18 simultaneous fluorescent parameters respectively. Both of these instruments are equipped with a high-throughput system for automation of 96-well plate analysis. Additionally, the facility has a pioneering high content, 9-laser, 30-parameter Fortessa X50 flow cytometer; with access to a suite of novel reagents and custom fluorochrome conjugations, the FCRF is in a position to offer world-leading, high-content flow cytometry capabilities to investigators at University of Nebraska. With the University of Nebraska currently investing and actively expanding its research infrastructure, the FCRF will become increasingly valuable to a growing research base over the coming five years. In the past 12 months there has been a strategic shift in operations at the FCRF, initiating a culture change in how researchers access flow cytometry services. This has given the FCRF the operational structure in place to support an increase in volume of use at the facility in the coming years and an increase in high-content flow cytometry applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA036727-34
Application #
9981649
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-09-05
Project End
2021-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
34
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Chhonker, Yashpal S; Sleightholm, Richard L; Li, Jing et al. (2018) Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci 1072:320-327
Lopez, Wilfredo; Page, Alexis M; Carlson, Darby J et al. (2018) Analysis of immune-related genes during Nora virus infection of Drosophila melanogaster using next generation sequencing. AIMS Microbiol 4:123-139
Iseka, Fany M; Goetz, Benjamin T; Mushtaq, Insha et al. (2018) Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. J Immunol 200:483-499
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Huang, Yunlong; Li, Yuju; Zhang, Hainan et al. (2018) Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869. Cell Discov 4:19
Kumar, Vinod; Kumar, Virender; Chaudhary, Amit Kumar et al. (2018) Impact of miRNA-mRNA Profiling and Their Correlation on Medulloblastoma Tumorigenesis. Mol Ther Nucleic Acids 12:490-503
Fan, Wei; Zhang, Wenting; Alshehri, Sameer et al. (2018) Increasing time on target: utilization of inhibitors of cysteine cathepsins to enhance the tumor retention of receptor-targeted agents. Chem Commun (Camb) 54:11268-11271
Baranovskiy, Andrey G; Siebler, Hollie M; Pavlov, Youri I et al. (2018) Iron-Sulfur Clusters in DNA Polymerases and Primases of Eukaryotes. Methods Enzymol 599:1-20
Ouellette, Scot P; Messerli, Parker R; Wood, Nicholas A et al. (2018) Characterization of Chlamydial Rho and the Role of Rho-Mediated Transcriptional Polarity during Interferon Gamma-Mediated Tryptophan Limitation. Infect Immun 86:
Robb, Caroline M; Kour, Smit; Contreras, Jacob I et al. (2018) Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget 9:5216-5232

Showing the most recent 10 out of 1372 publications